SB
ABMD

Suntrust Banks’s Abiomed Inc ABMD Stock Holding History

Suntrust Banks’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$249K Sell
1,397
-2,775
-67% -$600K ﹤0.01% 1185
2019
Q2 		$1.09M Sell
4,172
-294
-7% -$78K 0.01% 742
2019
Q1 		$1.28M Sell
4,466
-452
-9% -$150K 0.01% 692
2018
Q4 		$1.6M Sell
4,918
-5,100
-51% -$1.77M 0.01% 581
2018
Q3 		$4.5M Buy
10,018
+5,490
+121% +$2.16M 0.02% 343
2018
Q2 		$1.85M Buy
4,528
+503
+12% +$182K 0.01% 574
2018
Q1 		$1.17M Buy
+4,025
New +$1.02M 0.01% 679
2014
Q2 		– Sell
-47,163
Closed -$1.23M – 1749
2014
Q1 		$1.23M Sell
47,163
-43,716
-48% -$1.21M ﹤0.01% 862
2013
Q4 		$2.43M Sell
90,879
-563
-0.6% -$13.9K 0.01% 611
2013
Q3 		$1.74M Sell
91,442
-1,205
-1% -$27.5K 0.01% 690
2013
Q2 		$2M Buy
+92,647
New +$1.86M 0.01% 620

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Suntrust Banks's ABMD Position: Q3 2019 in Review

Suntrust Banks reduced its Abiomed Inc (ABMD) stake by 67% in Q3 2019, selling an estimated $600K and leaving 1,397 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Suntrust Banks first reported a position in ABMD in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.5M in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Suntrust Banks held 1,397 shares of Abiomed Inc worth $249K as of Q3 2019.
  • Suntrust Banks sold 2,775 Abiomed Inc shares in Q3 2019, an estimated $600K.
  • Abiomed Inc made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1185 holding.
  • Suntrust Banks first reported a position in Abiomed Inc in Q2 2013 and has held it in 11 quarters since.
  • Suntrust Banks's Abiomed Inc position peaked at $4.5M in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.